The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(Nov 2021)
Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors
Yusuke Suenaga,
Christer Einvik,
Christer Einvik,
Atsushi Takatori,
Yuyan Zhu,
Yuyan Zhu
Affiliations
Yusuke Suenaga
Department of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Japan
Christer Einvik
Department of Pediatrics, Division of Child and Adolescent Health, UNN - University Hospital of North-Norway, Tromsø, Norway
Christer Einvik
Pediatric Research Group, Department of Clinical Medicine, Faculty of Health Science, The Arctic University of Norway - UiT, Tromsø, Norway
Atsushi Takatori
Division of Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chiba, Japan
Yuyan Zhu
Joint Laboratory of Artificial Intelligence and Precision Medicine of China Medical University and Northeastern University, Shenyang, China
Yuyan Zhu
Department of Urology, The First Hospital of China Medical University, Shenyang, China
DOI
https://doi.org/10.3389/fonc.2021.803443
Journal volume & issue
Vol. 11
Abstract
Read online
No abstracts available.
Keywords
MYCN
neuroblastoma
brain tumor
hepatocellular carcinoma
therapeutic targets
WeChat QR code
Close